Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Integris Family Care South
mi
from
Oklahoma, OK
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Integris Family Care South
mi
from
Oklahoma, OK
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Southeastern Research Associates, Inc.
mi
from
Taylors, SC
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Southeastern Research Associates, Inc.
mi
from
Taylors, SC
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Abbott Clinical Research Group, Inc.
mi
from
San Antonio, TX
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Abbott Clinical Research Group, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Avastra Clinical Trials
mi
from
Midvale, UT
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Avastra Clinical Trials
mi
from
Midvale, UT
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Optimum Clinical Research
mi
from
Salt Lake City, UT
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Optimum Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Capital Clinical Research Center
mi
from
Olympia, WA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Capital Clinical Research Center
mi
from
Olympia, WA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Stephen G. Danley, Do
mi
from
Spokane, WA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Stephen G. Danley, Do
mi
from
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Local Institution
mi
from
Calgary,
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Local Institution
mi
from
Calgary,
Click here to add this to my saved trials
Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes
Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals
Status: Enrolling
Updated:  9/23/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes
Acute Cardiovascular and Metabolic Effects of Exercise Training in Individuals
Status: Enrolling
Updated: 9/23/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Marina Raikhel, Md
mi
from
Lomita, CA
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Marina Raikhel, Md
mi
from
Lomita, CA
Click here to add this to my saved trials
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Nevada Alliance Against Diabetes
mi
from
Las Vegas, NV
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Nevada Alliance Against Diabetes
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Local Institution
mi
from
Caboolture,
Safety Study of BMS-770767 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Local Institution
mi
from
Caboolture,
Click here to add this to my saved trials
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Farid Marquez, Md
mi
from
Hialeah, FL
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Farid Marquez, Md
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Capital Clinical Reserch Center
mi
from
Olympia, WA
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Capital Clinical Reserch Center
mi
from
Olympia, WA
Click here to add this to my saved trials
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated:  9/23/2015
Local Institution
mi
from
Blacktown,
Safety Study of BMS-823778 in Subjects With Type 2 Diabetes
A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-823778 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin
Status: Enrolling
Updated: 9/23/2015
Local Institution
mi
from
Blacktown,
Click here to add this to my saved trials
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
Status: Enrolling
Updated:  9/24/2015
Medical University of South Carolina
mi
from
Charleston, SC
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM
Status: Enrolling
Updated: 9/24/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Anaheim, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Chino, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
North Hollywood, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Spring Valley, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Tustin, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Miami, FL
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Port Orange, FL
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Marietta, GA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Chicago, IL
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Edina, MN
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
St Louis, MO
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Butte, MT
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Butte, MT
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Franklin, OH
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Franklin, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Marion, OH
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Marion, OH
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Mt Pleasant, SC
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Mt Pleasant, SC
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Rapid City, SD
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Corpus Christi, TX
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Houston, TX
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Katy, TX
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Katy, TX
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Burke, VA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Burke, VA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Manassas, VA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Manassas, VA
Click here to add this to my saved trials
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  9/24/2015
Clinical Research Facility
mi
from
Olympia, WA
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 9/24/2015
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
Laser Therapy for Diabetic Peripheral Neuropathic Pain
Laser Therapy Treatment of Peripheral Neuropathic Pain in Individuals With Diabetes
Status: Enrolling
Updated:  9/25/2015
University of Miami Miller School of Medicine, Clinical Research Building, Department of Psychiatry & Behavioral Sciences
mi
from
Miami, FL
Laser Therapy for Diabetic Peripheral Neuropathic Pain
Laser Therapy Treatment of Peripheral Neuropathic Pain in Individuals With Diabetes
Status: Enrolling
Updated: 9/25/2015
University of Miami Miller School of Medicine, Clinical Research Building, Department of Psychiatry & Behavioral Sciences
mi
from
Miami, FL
Click here to add this to my saved trials
Screening for Studies on Retinovascular Diseases
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Screening for Studies on Retinovascular Diseases
Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Blood Factors and Diabetic Retinopathy
Study of Association of Serum Factors With Diabetic Retinopathy
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Blood Factors and Diabetic Retinopathy
Study of Association of Serum Factors With Diabetic Retinopathy
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials